DAVID FARR: Open Payments
NPI 1548529241 · OPELIKA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,057 in 50 payments from 19 companies in 2025. Trend: 2023 $1,734 · 2024 $3,226 · 2025 $1,057
Food & beverage: $1,057
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 17 | $265 |
| Astellas Pharma US Inc | 6 | $120 |
| Otsuka America Pharmaceutical, Inc. | 1 | $103 |
| PFIZER INC. | 5 | $102 |
| Olympus America Inc. | 3 | $78 |
| TOLMAR, INC. | 3 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
| ABBVIE INC. | 2 | $36 |
| Dendreon Pharmaceuticals LLC | 1 | $34 |
| Ferring Pharmaceuticals Inc. | 1 | $30 |
Products named: XTANDI, ORGOVYX, GEMTESA, REXULTI, iTIND System, Nubeqa, JATENZO, LUPRON DEPOT.
Industry payments across AL — which companies pay providers there.
